Giant pharmaceutical GSK announces positive data for Endometrial cancer drug Dostarlimab
GlaxoSmithKline (GSK) oncology subsidiary Tesaro has unveiled promising data from its Phase I/II Garnet study evaluating dostarli...Read More
Showing posts with label dostarlimab as a monotherapy. Show all posts
Showing posts with label dostarlimab as a monotherapy. Show all posts
Subscribe to:
Posts
(
Atom
)
